S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-0.04%) $78.08
Gas
(0.61%) $2.16
Gold
(-0.21%) $2 303.80
Silver
(0.13%) $26.73
Platinum
(-0.69%) $958.60
USD/EUR
(0.01%) $0.929
USD/NOK
(-0.09%) $10.86
USD/GBP
(-0.02%) $0.797
USD/RUB
(0.00%) $91.45

Actualizaciones en tiempo real para Regen BioPharma, Inc. [RGBP]

Bolsa: OTC Sector: Healthcare Industria: Biotechnology
Última actualización3 may 2024 @ 15:57

15.79% $ 0.660

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 15:57):

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease...

Stats
Volumen de hoy 9 553.00
Volumen promedio 14 805.00
Capitalización de mercado 2.72M
EPS $-0.0311 ( 2024-04-24 )
Próxima fecha de ganancias ( $0 ) 2024-07-22
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.75
ATR14 $0.0150 (2.27%)

Regen BioPharma, Inc. Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Regen BioPharma, Inc. Finanzas

Annual 2023
Ingresos: $236 560
Beneficio Bruto: $176 560 (74.64 %)
EPS: $0.290
FY 2023
Ingresos: $236 560
Beneficio Bruto: $176 560 (74.64 %)
EPS: $0.290
FY 2022
Ingresos: $235 517
Beneficio Bruto: $185 517 (78.77 %)
EPS: $1.750
FY 2021
Ingresos: $171 194
Beneficio Bruto: $0.00 (0.00 %)
EPS: $-0.00225

Financial Reports:

No articles found.

Regen BioPharma, Inc.

Regen BioPharma, Inc. focuses on the development of regenerative medical applications in the United States. It engages in actively identifying small molecules that inhibit or express NR2F6 leading to immune cell activation for oncology applications, and immune cell suppression for autoimmune disease. The company is in the early stages of development of its products, and therapies. Regen BioPharma, Inc. was incorporated in 2012 and is based in La Mesa, California.

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico